Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Simcere Pharmaceutical Group Limited ( (HK:2096) ) just unveiled an announcement.
Simcere Pharmaceutical Group Limited announced a final cash dividend of RMB 0.16 per share for the year ended December 31, 2024, with payment to be made in Hong Kong dollars at an exchange rate of RMB 1 to HKD 1.092514. The dividend reflects the company’s financial performance and commitment to returning value to its shareholders, with the payment date set for July 14, 2025, following the record date on June 24, 2025.
More about Simcere Pharmaceutical Group Limited
Simcere Pharmaceutical Group Limited is a company operating in the pharmaceutical industry, focusing on the development, production, and distribution of pharmaceutical products. The company is known for its commitment to innovation and providing high-quality medical solutions.
Average Trading Volume: 12,094,656
Technical Sentiment Signal: Buy
Current Market Cap: HK$30.44B
For a thorough assessment of 2096 stock, go to TipRanks’ Stock Analysis page.